Delving into the Latest Updates on DVC-01 with Synapse

Overview

Basic Info

Drug Type

Small molecule drug

Synonyms-

Target-

Action-

Mechanism-

Therapeutic Areas

Immune System DiseasesSkin and Musculoskeletal DiseasesOther Diseases

Active Indication

Bites and StingsDermatitis, OccupationalDermatitis, Seborrheic+ [7]

Inactive Indication

Dermatitis, AtopicDermatophilosisVaricose Veins

Originator Organization

Tianjin Pharm Research Inst Pharm Co Ltd.

Active Organization

Tianjin Pharmaceutical Research Institute Co Ltd.

Inactive Organization

Tianjin Pharm Research Inst Pharm Co Ltd.

Drug Highest PhasePhase 3

First Approval Date-

Regulation-

Login to view timeline

主要目的：初步评价中国健康受试者经完整皮肤单次外用戊酸二氟可龙乳膏时，戊酸二氟可龙及二氟可龙的全身吸收情况和药代动力学特征。次要目的：初步评价中国健康受试者经完整皮肤单次外用戊酸二氟可龙乳膏时，用药局部和全身的安全性。

[Translation]

Primary objective: To preliminarily evaluate the systemic absorption and pharmacokinetic characteristics of diflucortolone valerate and diflucortolone when diflucortolone valerate cream is applied to Chinese healthy subjects via intact skin once. Secondary objective: To preliminarily evaluate the local and systemic safety of diflucortolone valerate cream when applied to Chinese healthy subjects once via intact skin once.

Start Date07 Jan 2020

Sponsor / Collaborator

Tianjin Pharmaceutical Research Institute Co Ltd.

CTR20190509

/ RecruitingPhase 3

DVC-01治疗湿疹的有效性和安全性多中心、随机、双盲、赋形剂平行对照临床研究

[Translation] Efficacy and safety of DVC-01 in the treatment of eczema: a multicenter, randomized, double-blind, vehicle-controlled clinical study

评价DVC-01治疗湿疹的有效性和安全性。

[Translation]

To evaluate the efficacy and safety of DVC-01 in the treatment of eczema.

Start Date05 Nov 2018

Sponsor / Collaborator

Tianjin Pharmaceutical Research Institute Co Ltd.

100 Clinical Results associated with DVC-01

Login to view more data

100 Translational Medicine associated with DVC-01

Login to view more data

100 Patents (Medical) associated with DVC-01

Login to view more data

100 Deals associated with DVC-01

Login to view more data

R&D Status

10 top R&D records.

Login

to view more data

Indication	Highest Phase	Country/Location	Organization	Date
Bites and Stings	Phase 3	China	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Dermatitis, Occupational	Phase 3	China	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Dermatitis, Seborrheic	Phase 3	China	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Eczema, Dyshidrotic	Phase 3	China	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Lichen Planus	Phase 3	China	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Lupus Erythematosus, Discoid	Phase 3	China	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Neurodermatitis	Phase 3	China	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Nummular eczema	Phase 3	China	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Psoriasis	Phase 3	China	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018
Sunburn	Phase 3	China	Tianjin Pharmaceutical Research Institute Co Ltd.	05 Nov 2018